2017
DOI: 10.25141/2475-3432-2017-6.0165
|View full text |Cite
|
Sign up to set email alerts
|

Hematological manifestation in Down Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…TAM is estimated to occur in approximately 10% of newborns with Down syndrome. Although it is transient, a small number develop serious or even fatal complications such as hepatic brosis or edema, and 20% of those who recover from TAM develop acute megakaryoblastic leukemia [5].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…TAM is estimated to occur in approximately 10% of newborns with Down syndrome. Although it is transient, a small number develop serious or even fatal complications such as hepatic brosis or edema, and 20% of those who recover from TAM develop acute megakaryoblastic leukemia [5].…”
Section: Discussionmentioning
confidence: 99%
“…This chromosomal anomaly causes intellectual disability, speci c phenotypic characteristics, and a combination of systemic conditions [1,2]. Among the hematological alterations seen are leukemia, transient abnormal myelopoiesis, neutrophilia, and thrombocytopenia with giant platelets [3][4][5][6][7]. Macrocytosis, thrombocytosis, and leukopenia have been reported in older children [8,9].…”
Section: Introductionmentioning
confidence: 99%